EMD SERONO: * EMD SERONO ANNOUNCES UNPRECEDENTED AGREEMENT WITH U.S. GOVERNMENT TO EXPAND ACCESS TO IVF THERAPIES

* EMD SERONO: WILL FILE PERGOVERIS FOR REVIEW UNDER THE FDA COMMISSIONER'S NATIONAL PRIORITY VOUCHER PROGRAM * EMD SERONO: WILL PARTICIPATE IN THE TRUMPRX.GOV DIRECT PURCHASING PLATFORM

* EMD SERONO: ENTERED AGREEMENT WITH THE U.S. SECRETARY OF COMMERCE TO EXCLUDE ITS PHARMACEUTICAL PRODUCTS, INGREDIENTS FROM SECTION 232 TARIFFS * EMD SERONO: WHEN ALL THREE OF ITS IVF THERAPIES ARE USED IN A TYPICAL IVF PROTOCOL, PATIENTS WILL ACCESS AN 84% DISCOUNT OFF LIST PRICES Further company coverage:

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

See Full Page